Top Markets
#1 Siacoin Siacoin +33.02%
#2 Official Trump Official Trump +23.94%
#3 EXOD EXOD +18.93%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.60%
#5 MowCat MowCat +17.88%
#6 Melania Meme Melania Meme +17.83%
#7 Unit Pump Unit Pump +16.67%
#8 Pump.fun Pump.fun +16.67%
#9 Siren Siren +14.85%
#10 The Bitcoin Bull The Bitcoin Bull +14.83%
Coin of the day
Siacoin Siacoin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Classifica tra le azioni #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Prezzo delle azioni
$4.00
Ultima sincronizzazione: 2026-08-20
Capitalizzazione di mercato
$75.37M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
12.99%
Paese
US
Scambia RetinalGenix Technologies Inc. (RTGN)

Categoria

Healthcare
Ricavi di RetinalGenix Technologies Inc. (RTGN)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di RetinalGenix Technologies Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per RetinalGenix Technologies Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE